ZOLL Medical Corporation Acquires Respicardia, Inc.

April 12, 2021

ZOLL Medical Corporation, an Asahi Kasei company, acquired Respicardia, Inc., the developer of the implantable remēde® System for treating moderate to severe Central Sleep Apnea (CSA). The acquisition brings Respicardia’s FDA-approved neurostimulation technology and employees into ZOLL’s cardiac and respiratory care portfolio to expand treatment capabilities and global reach.

Buyers
ZOLL Medical Corporation
Targets
Respicardia, Inc.
Industry
Medical Devices
Location
Minnesota, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.